U.S. Food and Drug Administration Clears UVision360, Inc. Novel LUMINELLE(R) 360° Bx (Biopsy) Sheath

First and only integrated directed biopsy device when combined with the LUMINELLE DTx System RALEIGH, N.C., July 7, 2021 -- (Healthcare Sales & Marketing Network) -- UVision360, Inc., an innovative medical device company, announces today that the U.S. ... Devices, FDA UVision360, LUMINELLE 360°, LUMINELLE DTx

https://salesandmarketingnetwork.com/news_release_bs.html?ID=2047001

Source: HSMN NewsFeed - July 7, 2021 Category: Pharmaceuticals Source Type: news

More News: Food and Drug Administration (FDA) | Marketing | Medical Devices | Pharmaceuticals